HeartBeam (NASDAQ: BEAT), a medical-technology company developing advanced electrocardiogram solutions, was featured in ...
After dumping its sole remaining gene therapy asset last year, Pfizer has decided to exercise its option for global rights to Beam Therapeutics’ liver-targeted gene editing candidate.
Embark Studios has published full patch notes for Arc Raiders update 1.17.0, revealing a wave of nerfs for PvP and PvE ...